TrialESMO open2026

Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung).

K He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.